Table 4.
Clinical Outcomes
| Measure | Imaging/clinical examination |
|---|---|
| N | 167 |
| Followed at 6 months | 153 (92%) |
| Primary outcome: 21-element composite1 median (IQR) | 53 (21, 76) |
| 6-month cumulative mortality | 41% |
| 6-month GOS-E | |
| Death (1) | 67 (44%2) |
| Unfavorable (2-4) | 26 (17%) |
| Favorable (5-8) | 60 (39%) |
1
Composite is average percentile over the 21 elements. Range: 0 to 100, higher is better.
2
Higher than estimated cumulative mortality above because participants who were lost to follow-up are excluded from the 6-month GOS-E but included as censored observations for the cumulative mortality.
IQR, interquartile range; GOS-E, extended Glasgow Outcome Score.